Advances in dissolution instrumentation and their practical applications

References

• Gray V, Kelly G, Xia M, et al. The science of USP 1 and 2 dissolution: present challenges and future relevance. Pharm Res 2009;26:1289–302
   PubMed Web of Science ®Google Scholar
• Röst M, Quist PO. Dissolution of USP prednisone calibrator tablets. J Pharm Biomed Anal 2003;31:1129–43
   PubMed Web of Science ®Google Scholar
• Beckett AH, Quach TT, Kurs GS. Improved hydrodynamics for USP apparatus 2. Dissolut Technol 1996;3:7–18
   Google Scholar
• Baxter JL, Kukura J, Muzzio FJ. Shear-induced variability in the United States Pharmacopeia Apparatus 2: modifications to the existing system. AAPS J 2005;7:E857–64
   Web of Science ®Google Scholar
• Qureshi SA. Comparative impact of stirring and shearing in drug dissolution testing with USP paddle and crescent-shaped spindles. Dissolut Technol 2006;13:25–30
   Google Scholar
• Wang Y, Armenante PM. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms. J Pharm Sci 2012;101:746–60
   PubMed Web of Science ®Google Scholar
• Butler WCG, Bateman SR. A flow-through dissolution method for a two component drug formulation where the actives have markedly differing solubility properties. Int J Pharm 1998;173:211–19
   Web of Science ®Google Scholar
• Shiko G, Gladden LF, Sederman AJ, et al. MRI studies of the hydrodynamics in a USP 4 dissolution testing cell. J Pharm Sci 2011;100:976–91
   PubMed Web of Science ®Google Scholar
• Dorozynski PP, Kulinowski P, Mendyk A, et al. Novel application of MRI technique combined with flow-through cell dissolution apparatus as supportive discriminatory test for evaluation of controlled release formulations. AAPS PharmSciTech 2010;11:588–97
   PubMed Web of Science ®Google Scholar
• Kulinowski P, Dorozynski P, Mlynarczyk A, Weglarz WP. Magnetic resonance imaging and image analysis for assessment of HPMC matrix tablets structural evolution in USP Apparatus 4. Pharm Res 2011;28:1065–73
   PubMed Web of Science ®Google Scholar
• Tajiri T, Morita S, Sakamoto R, et al. Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging. Int J Pharm 2010;395:147–53
   PubMed Web of Science ®Google Scholar
• Zhang Q, Gladden L, Avalle P, Mantle M. In vitro quantitative ((1))H and ((19))F nuclear magnetic resonance spectroscopy and imaging studies of fluvastatin in Lescol(R) XL tablets in a USP-IV dissolution cell. J Control Release 2011;156:345–54
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeial Convention. USP 28. Rockville, MD: United States Pharmacopeial Convention Inc.; 2005
   Google Scholar
• Phillips DJ, Pygall SR, Cooper VB, Mann JC. Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems. J Pharm Pharmacol 2012;64:1549–59
   PubMed Web of Science ®Google Scholar
• Mudie DM, Shi Y, Ping H, et al. Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus. Biopharm Drug Dispos 2012;33:378–402
   PubMed Web of Science ®Google Scholar
• Heigoldt U, Sommer F, Daniels R, Wagner KG. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. Eur J Pharm Biopharm 2010;76:105–11
   PubMed Web of Science ®Google Scholar
• Grundy JS, Anderson KE, Rogers JA, Foster RT. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test. J Control Release 1997;48:1–8
   Web of Science ®Google Scholar
• Grundy JS, Anderson KE, Rogers JA, Foster RT. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II. Improved in vitro--in vivo correlation using a two-phase dissolution test. J Control Release 1997;48:9–17
   Web of Science ®Google Scholar
• Vangani S, Li X, Zhou P, et al. Dissolution of poorly water-soluble drugs in biphasic media using USP 4 and fiber optic system. Clin Res Regul Aff 2009;26:8–19
   Google Scholar
• Kataoka M, Itsubata S, Masaoka Y, et al. In vitro dissolution/permeation system to predict the oral absorption of poorly water-soluble drugs: effect of food and dose strength on it. Biol Pharm Bull 2011;34:401–7
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Sada N, Sugawara M, et al. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. Int J Pharm 2001;221:87–94
   PubMed Web of Science ®Google Scholar
• Hou J, He X, Xu X, et al. Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro--in vivo correlation. Drug Dev Ind Pharm 2012;38:1305–12
   PubMed Web of Science ®Google Scholar
• Ginski MJ, Polli JE. Prediction of dissolution--absorption relationships from a dissolution/Caco-2 system. Int J Pharm 1999;177:117–25
   PubMed Web of Science ®Google Scholar
• Gao Z. Development of a continuous dissolution/absorption system – a technical note. AAPS PharmSciTech 2012;13:1287–92
   PubMed Web of Science ®Google Scholar
• Marasanapalle VP, Crison JR, Devarakonda KR, et al. Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics. Drug Dev Ind Pharm 2011;37:1429–38
   PubMed Web of Science ®Google Scholar
• Augustijns P, Brewster ME. Supersaturating drug delivery systems: fast is not necessarily good enough. J Pharm Sci 2012;101:7–9
   PubMed Web of Science ®Google Scholar
• Six K, Daems T, de Hoon J, et al. Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur J Pharm Sci 2005;24:179–86
   PubMed Web of Science ®Google Scholar
• Kostewicz ES, Wunderlich M, Brauns U, et al. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J Pharm Pharmacol 2004;56:43–51
   PubMed Web of Science ®Google Scholar
• Psachoulias D, Vertzoni M, Butler J, et al. An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine. Pharm Res 2012;29:3486–98
   PubMed Web of Science ®Google Scholar
• Carino SR, Sperry DC, Hawley M. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. J Pharm Sci 2006;95:116–25
   PubMed Web of Science ®Google Scholar
• Polster CS, Atassi F, Wu SJ, Sperry DC. Use of artificial stomach-duodenum model for investigation of dosing fluid effect on clinical trial variability. Mol Pharm 2010;7:1533–8
   PubMed Web of Science ®Google Scholar
• Parikh RK, Parikh DC, Delvadia RR, Patel SM. A novel multicompartment dissolution apparatus for evaluation of floating dosage form containing poorly soluble weakly basic drug. Dissolut Technol 2006;13:14–19
   Google Scholar
• Cassilly D, Kantor S, Knight LC, et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil 2008;20:311–19
   PubMed Web of Science ®Google Scholar
• Goodman K, Hodges LA, Band J, et al. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. Eur J Pharm Biopharm 2010;74:84–92
   PubMed Web of Science ®Google Scholar
• Garbacz G, Klein S, Weitschies W. A biorelevant dissolution stress test device – background and experiences. Expert Opin Drug Deliv 2010;7:1251–61
   PubMed Web of Science ®Google Scholar
• Garbacz G, Wedemeyer RS, Nagel S, et al. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Eur J Pharm Biopharm 2008;70:421–8
   PubMed Web of Science ®Google Scholar
• Garbacz G, Blume H, Weitschies W. Investigation of the dissolution characteristics of nifedipine extended-release formulations using USP apparatus 2 and a novel dissolution apparatus. Dissolut Technol 2009;16:7–13
   Web of Science ®Google Scholar
• Garbacz G, Golke B, Wedemeyer RS, et al. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. Eur J Pharm Sci 2009;38:147–55
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Pal A, Sjoberg M, et al. A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach. Pharm Res 2005;22:1215–26
   PubMed Web of Science ®Google Scholar
• Wickham MJS, Faulks RM, Mann J, Mandalari G. The design, operation, and application of a dynamic gastric model. Dissolut Technol 2012;19:15–22
   Web of Science ®Google Scholar
• Hörter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001;46:75–87
   PubMed Web of Science ®Google Scholar
• Fotaki N, Vertzoni M. Biorelevant dissolution methods and their applications in in vitro--in vivo correlations for oral formulations. Open Drug Deliv J 2010;4:2–13
   Google Scholar
• Wang Q, Fotaki N, Mao Y. Biorelevant dissolution: methodology and application in drug development. Dissolut Technol 2009;16:6–12
   Web of Science ®Google Scholar
• Kostewicz E, Brauns U, Becker R, Dressman J. Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. Pharm Res 2002;19:345–9
   PubMed Web of Science ®Google Scholar
• Löbenberg R, Kramer J, Shah VP, et al. Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide. Pharm Res 2000;17:439–44
   PubMed Web of Science ®Google Scholar
• Brouwers J, Anneveld B, Goudappel GJ, et al. Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system. Eur J Pharm Biopharm 2011;77:313–19
   PubMed Web of Science ®Google Scholar
• Souliman S, Beyssac E, Cardot JM, et al. Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system. Drug Dev Ind Pharm 2007;33:475–83
   PubMed Web of Science ®Google Scholar
• Souliman S, Blanquet S, Beyssac E, Cardot JM. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Eur J Pharm Sci 2006;27:72–9
   PubMed Web of Science ®Google Scholar